Argentine companies operating in the same pharmaceuticals: major industry

The table below has Argentine companies that operate under the same industry, pharmaceuticals: major. This list helps you analyze each company’s performance, income statements, and stock activity — all in one place. Sort by key metrics to find the most expensive stocks like ASTRAZENECA PLC CEDEAR EACH REP 0.5 ADR USD0.25, or spot the most traded options, such as INSTITUTO ROSENBUCH SA DE BIOLOGIA. Ideal for investors and traders looking to build or refine a strategy within this growing tech segment.
Symbol
Market cap
Price
Change %
Volume
Rel Volume
P/E
EPS dil
TTM
EPS dil growth
TTM YoY
Div yield %
TTM
Sector
Analyst Rating
LLYCELI LILLY AND COMPANY CEDEAR EACH 4 REPR 1 ORD NPV (USD)
DR
905.77 T ARS13.65 USD+90.91%13.74 K69.54210.62 ARS+167.86%0.44%Health technology
LLYDELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 (USD)
DR
905.77 T ARS14.55 USD+0.34%1280.1374.12210.62 ARS+167.86%0.44%Health technology
LLYELI LILLY AND COMPANY CEDEAR EACH 56 REP 1
DR
905.77 T ARS17,400 ARS+1.31%9.86 K0.7182.61210.62 ARS+235.69%0.44%Health technology
JNJDJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS(USD)
DR
441.98 T ARS10.50 USD0.00%5330.9618.86597.27 ARS+144.56%1.82%Health technology
DJN3DJOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS)
DR
441.98 T ARS1.300 USD0.00%20.00Health technology
JNJJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS
DR
441.98 T ARS12,425 ARS0.00%11.3 K1.9720.80597.27 ARS+206.49%1.82%Health technology
DJNJ3JOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS)
DR
441.98 T ARS1,300 ARS0.00%530.01Health technology
ABBVDABBVIE INC CEDEAR EA 10 REP 1 COM(USD)
DR
398.98 T ARS19.40 USD+0.52%1823.519.272,245.57 ARS+26.43%1.89%Health technology
ABBVABBVIE INC CEDEAR EACH 10 REPR 1 COM
DR
398.98 T ARS22,750 ARS−0.55%1.23 K0.9610.132,245.57 ARS+58.44%1.89%Health technology
AZNDASTRAZENECA PLC CEDEAR EA RE 0.5 ADR (USD)
DR
269.45 T ARS37.15 USD+0.81%70.3240.79977.22 ARS+96.72%1.58%Health technology
AZNASTRAZENECA PLC CEDEAR EACH REP 0.5 ADR USD0.25
DR
269.45 T ARS44,375 ARS−0.39%3310.9445.41977.22 ARS+146.53%1.58%Health technology
NVSNOVARTIS AG CEDEAR EACH 4 REP 1
DR
266.12 T ARS35,600 ARS−1.11%9634.935.186,872.32 ARS+10.89%3.63%Health technology
MRKDMERCK & CO INC CEDEAR EAC 5 RE 1 (USD)
DR
240.58 T ARS16.25 USD−1.22%5192.1513.091,332.07 ARS+283.54%2.07%Health technology
MRKCMERCK & CO INC CEDEAR (5 REP 1 USD0.50)
DR
240.58 T ARS15.55 USD−0.32%27.53 K12.531,332.07 ARS+283.54%2.07%Health technology
MRKMERCK & CO INC CEDEAR (5 REP 1 USD0.50)
DR
240.58 T ARS19,375 ARS−0.51%3.58 K0.6814.551,332.07 ARS+380.66%2.07%Health technology
PFECPFIZER INC CEDEAR EACH 2 REP 1 ORD USD0.05
DR
164.17 T ARS6.40 USD+11.11%220.0020.17340.44 ARS+582.03%4.02%Health technology
PFEDPFIZER INC CEDEAR 4 REP 1 ORD USD0.05(USD)
DR
164.17 T ARS6.15 USD−0.81%2.7 K1.8619.38340.44 ARS+582.03%4.02%Health technology
PFEPFIZER INC CEDEAR EACH 4 REP 1 ORD USD0.05
DR
164.17 T ARS7,300 ARS−0.95%10.17 K0.8321.44340.44 ARS+754.74%4.02%Health technology
VRTXVERTEX PHARMACEUTICAL CEDEAR EACH 101 REPR 1 ORD
DR
137.03 T ARS5,400 ARS−0.74%2710.34−245,320.18 ARS−133.72%0.00%Health technology
BMYDBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1 USD
DR
117.19 T ARS16.00 USD−4.19%6586.5019.81866.77 ARS3.41%Health technology
BMYBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1
DR
117.19 T ARS19,750 ARS−1.50%1.67 K0.8422.79866.77 ARS3.41%Health technology
GSKDGSK PLC CEDEAR EACH REPR 1/4 ADR (USD)
DR
96.66 T ARS10.30 USD−0.48%1072.7223.26475.21 ARS+32.57%3.14%Health technology
GSKGSK PLC CEDEAR EACH REPR 1/4 ADR
DR
96.66 T ARS12,225 ARS−2.98%2620.8125.73475.21 ARS+66.14%3.14%Health technology
BIIBDBIOGEN INC CEDEAR EAC 13 RE 1 COM(USD)
DR
22.72 T ARS10.15 USD−1.93%40.0814.75738.48 ARS+101.66%0.00%Health technology
BIIBBIOGEN INC CEDEAR EACH 13 REP 1 COM USD0.0005
DR
22.72 T ARS11,925 ARS−1.45%1.09 K0.4516.15738.48 ARS+152.73%0.00%Health technology
RICHLABORATORIOS RICHMOND SACIF
117.09 B ARS1,450 ARS+2.11%9.71 K1.635.52262.78 ARS1.85%Health technology
ROSEINSTITUTO ROSENBUCH SA DE BIOLOGIA
16.18 B ARS380.0 ARS+0.40%268.37 K0.5389.024.27 ARS+64.50%0.00%Health technology